Medlive Technology Co's EBIT per Share for the
six
months ended in Dec. 2023 was HK$0.23.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.38.
During the past 12 months, the average EBIT per Share Growth Rate of Medlive Technology Co was 10.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -13.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 28.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medlive Technology Co's EBIT per Share or its related term are showing as below:
HKSE:02192'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -13.3 Med: 19.8 Max: 73.9
Current: -13.3
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Medlive Technology Co was 73.90% per year. The lowest was -13.30% per year. And the median was 19.80% per year.
HKSE:02192's 3-Year EBIT Growth Rate is ranked worse than 85.19% of 81
companies
in the Medical Distribution industry
Industry Median: 9.1
vs HKSE:02192: -13.30
Medlive Technology Co EBIT per Share Historical Data
The historical data trend for Medlive Technology Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.38
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medlive Technology Co EBIT per Share Related Terms
Thank you for viewing the detailed overview of Medlive Technology Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Medlive Technology Co (HKSE:02192) Business Description
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02192 has been successfully added to your 